Skip to main content
    B

    Becton Dickinson and Company (BDX)

    Official site

    HEALTHCARE • MEDICAL INSTRUMENTS & SUPPLIES • NYSE

    $216.50
    -1.53 (-0.70%)

    Market Cap: $59.39B

    Last updated: Nov 17, 2026 at 11:05 AM ET

    Becton Dickinson and Company (BDX) P/E Ratio & Valuation History

    Updated Nov 17, 2026. Multiples are computed from end-of-day prices, company filings and consensus analyst estimates.

    Becton Dickinson and Company (BDX) trades at 16.4x trailing earnings and 2.6x sales. Its P/E of 16.4x is below its 5-year median of 18.9x. Its forward P/E is 16.4x. The median P/E across 12 similar companies is 20.9x.

    Current Multiples

    Its enterprise value is 15.6x its EBITDA. Its free cash flow yield is 5.4%.

    MultipleValue
    P/E (trailing)16.4x
    Forward P/E16.4x
    Price to sales2.6x
    Price to book2.4x
    EV/EBITDA15.6x
    Price to FCF18.4x
    EV/FCF23.4x
    PEG1.0
    FCF yield5.4%
    As of Nov 17, 2026

    Historical Medians

    Against its 10-year medians, its P/E is 20.0% below 20.5x, its P/S is 31.6% below 3.8x and its P/B is 17.2% below 2.9x.

    MultipleCurrent5-year median10-year median
    P/E16.4x18.9x20.5x
    P/S2.6x3.5x3.8x
    P/B2.4x2.7x2.9x
    Medians of month-end values through Oct 2026: 60 months (5-year) and 120 months (10-year).

    Valuation History

    Over the 10 year ends shown, its P/E ranged from 14.0x in 2025 to 23.4x in 2019. 2025 was the lowest of those years.

    Year endPriceP/EP/SP/B
    2025$194.0714.0x2.5x2.2x
    2024$226.8716.3x3.2x2.6x
    2023$243.8320.5x3.6x2.8x
    2022$254.3022.0x3.9x2.8x
    2021$251.4820.7x3.9x3.0x
    2020$250.2220.7x4.2x2.9x
    2019$271.9723.4x4.3x3.5x
    2018$225.3220.1x3.5x2.8x
    2017$214.0622.2x4.1x2.7x
    2016$165.5518.4x2.9x4.6x
    Each year's multiples use the split-adjusted closing price of that year's last trading day over trailing per-share results as reported; periods with losses are left out.

    GNG Valuation

    GNG viewFairly valued

    GNG fair value is part of GNG Pro. See plans

    Frequently Asked Questions About BDX

    What is BDX's forward P/E ratio?

    Becton Dickinson and Company has a forward P/E ratio of 16.4x.

    Is BDX stock overvalued?

    GNG's valuation label for BDX is Fairly valued. Its P/E of 16.4x compares with a median of 20.9x across 12 similar companies.

    What is BDX's price to sales ratio?

    Becton Dickinson and Company has a price to sales ratio of 2.6x.

    What is Becton Dickinson and Company's average P/E ratio over 5 years?

    Becton Dickinson and Company's median P/E over the last 5 years is 18.9x, from 60 month-end values through Oct 2026.

    What is BDX's PEG ratio?

    Becton Dickinson and Company has a PEG ratio of 1.0.